 Antitubercular Agents
"Antitubercular Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
| Descriptor ID |
D000995
|
| MeSH Number(s) |
D27.505.954.122.085.255
|
| Concept/Terms |
Antitubercular Agents- Antitubercular Agents
- Agents, Antitubercular
- Antitubercular Drugs
- Drugs, Antitubercular
- Tuberculostatic Agents
- Agents, Tuberculostatic
|
Below are MeSH descriptors whose meaning is more general than "Antitubercular Agents".
Below are MeSH descriptors whose meaning is more specific than "Antitubercular Agents".
This graph shows the total number of publications written about "Antitubercular Agents" by people in this website by year, and whether "Antitubercular Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 2 | 3 | | 2008 | 1 | 0 | 1 | | 2009 | 0 | 3 | 3 | | 2011 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2013 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2016 | 0 | 2 | 2 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antitubercular Agents" by people in Profiles.
-
Glatstein M, Carbell G, Scolnik D, Rimon A, Banerji S, Hoyte C. Pyridoxine for the treatment of isoniazid-induced seizures in intentional ingestions: The experience of a national poison center. Am J Emerg Med. 2018 10; 36(10):1775-1778.
-
Kordy F, Waters V, Den-Hollander C, Read S, Lam R, Kitai I. Optimizing Blood Collection and Processing for Quantiferon-TB Gold in-Tube Testing Gives Low Rates of Indeterminate Results: Clinical Implications. Pediatr Infect Dis J. 2018 Jan; 37(1):e22-e24.
-
Tanvejsilp P, Pullenayegum E, Loeb M, Dushoff J, Xie F. Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand. J Clin Pharm Ther. 2017 Jun; 42(3):337-344.
-
Xu JJ, Peer S, Papsin BC, Kitai I, Propst EJ. Tuberculous lymphadenitis of the head and neck in Canadian children: Experience from a low-burden region. Int J Pediatr Otorhinolaryngol. 2016 Dec; 91:11-14.
-
Rayment JH, Guthrie JL, Lam K, Whelan M, Lee B, Jamieson FB, Kitai I. Culture-positive Pediatric Tuberculosis in Toronto, Ontario: Sources of Infection and Relationship of Birthplace and Mycobacterial Lineage to Phenotype. Pediatr Infect Dis J. 2016 Jan; 35(1):13-8.
-
Khan S, Stimec J, Kitai I. Nonresponding osteomyelitis in a two-year-old boy. CMAJ. 2015 Sep 08; 187(12):901-4.
-
Taweevisit M, Nisagornsen C, Thorner PS. Intrauterine Tuberculosis Manifesting as Acute Chorioamnionitis: A Case Report and Review of the Literature. Pediatr Dev Pathol. 2015 Jul-Aug; 18(4):335-8.
-
Science M, Ito S, Kitai I. Isoniazid toxicity in a 5-year-old boy. CMAJ. 2013 Jul 09; 185(10):894-6.
-
Thampi N, Stephens D, Rea E, Kitai I. Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors. Pediatr Infect Dis J. 2012 Feb; 31(2):129-33.
-
Al-Dabbagh M, Lapphra K, McGloin R, Inrig K, Schaaf HS, Marais BJ, Sauve L, Kitai I, Kollmann TR. Drug-resistant tuberculosis: pediatric guidelines. Pediatr Infect Dis J. 2011 Jun; 30(6):501-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|